Phosphorylation of Galphas influences its association with the micro-opioid receptor and is modulated by long-term

Sumita Chakrabarti1, Alan R Gintzler

  • 1Department of Biochemistry, State University of New York, Downstate Medical Center, Brooklyn, NY 11203, USA.

Insights

Long-term morphine treatment reduces Galpha(s) phosphorylation, increasing its association with the mu-opioid receptor (MOR). This phosphorylation state is key to MOR-Galpha(s) interaction in opioid tolerance.

Area of Science:

  • Neuroscience
  • Molecular Pharmacology
  • Biochemistry

Background:

  • The mu-opioid receptor (MOR) associates with Galpha(s) following chronic morphine exposure.
  • Understanding the mechanisms modulating MOR-Galpha(s) interactions is crucial for studying opioid tolerance.

Purpose of the Study:

  • To investigate the role of Galpha(s) phosphorylation in MOR-Galpha(s) association.
  • To elucidate neurochemical changes induced by long-term morphine treatment that affect MOR-Galpha(s) binding.

Main Methods:

  • Biochemical assays to assess Galpha(s) phosphorylation status.
  • In vitro experiments to determine the effect of dephosphorylation on Galpha(s)-MOR interaction.
  • Analysis in cell lines (CHO, F11) and spinal cord tissue.

Main Results:

  • Galpha(s) functions as a phosphoprotein.
  • Long-term morphine treatment significantly reduces Galpha(s) phosphorylation.
  • In vitro dephosphorylation of Galpha(s) enhances its binding to MOR.
  • Increased association with protein phosphatase 2A correlates with reduced Galpha(s) phosphorylation.

Conclusions:

  • The phosphorylation state of Galpha(s) is a critical regulator of its interaction with MOR.
  • Reduced Galpha(s) phosphorylation is a key mechanism underlying increased MOR-Galpha(s) association in opioid-tolerant states.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...